Latest Posts Articles

Two targets were chosen for their novelty – transcription factor CEBPB and transport protein MX2, both reported to be associated to Lupus in 2022.

Toll-like receptor 7 (TLR7) has long been implicated in lupus. Now scientists are uncovering precisely how. 

Lupus is an autoimmune disease which affects about 1 in 1000 people, which commonly causes joint pain, skin rashes and tiredness. Treatment options are improving for patients with lupus, and the target discovery landscape is heating up.